Skip to main content

Equibles does not estimate personal net worth.

Get an email with a short summary when Black Diamond Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.

Get BDTX alerts

About Fang Ni, Pharm. D.

Fang Ni, Pharm. D. is recorded as CFO at Black Diamond Therapeutics, Inc. (BDTX) since November 19, 2021. Black Diamond Therapeutics, Inc. reported in an 8-K filed November 22, 2021 that Fang Ni, Pharm. D. was appointed Interim Chief Financial Officer, effective November 19, 2021. Black Diamond Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Black Diamond Therapeutics, Inc. includes Mark A. Velleca (CEO), Mark A. Velleca, M.D., Ph.D. (CEO and Chairman), Mark Velleca (CEO and Board Member) and 7 others.

“Effective November 19, 2021, the Board of Directors of the Company \(the “**Board**”\) appointed Fang Ni, Pharm. D., the Company’s Chief Business Officer, as Interim Chief Financial Officer and principal financial officer until a successor is appointed.”
Black Diamond Therapeutics, Inc. Form 8-K, filed November 22, 2021 · Read the filing

Affiliation history

Company network

Leadership on record at Black Diamond Therapeutics, Inc.

Recent activity